Uncategorized

Regarding Inheriting of Shares of Olainfarm Owned by Valerijs Maligins

on January 16, 2018

Today, on January 16, 2018, Certified Notary Valda Vaivare read out the Testament of Valerijs Maligins, long term Chairman of the Board and co-owner of JSC Olainfarm, who suddenly passed away last month.

According to the Testament, shares of JSC Olainfarm and shares of Olmafarm Ltd. shall be inherited by all children of Mr. Maligins in equal parts, with the condition that they are not allowed to sell, present or otherwise alienate them during the five-year period after the inheritance is received. Valerijs Maligins owned 3 791 810 shares of JSC Olainfarm and 100% shares in Olmafarm Ltd., which owns another 5 994 054 shares of JSC Olainfarm.

All heirs, creditors and other entities having claims on the inheritance may submit them before April 13, 2018.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
SigitaRegarding Inheriting of Shares of Olainfarm Owned by Valerijs Maligins

Olainfarm will Hold Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

on January 8, 2018

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on January 11, 2018 at 16:00 (EET). To join the webinar please follow the instructions below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the financial results of the third quarter 2017.

After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance until January 10, 2018 to e-mail: elizabete.kalnozola@nasdaq.com.

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via http://ej.uz/OLFQ3.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.  

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm will Hold Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

Transactions concluded by management

on January 2, 2018

JSC Olainfarm has received the notification of manager on transactions with securities issued by JSC Olainfarm. The received notification is available in attachment: pazinojums-dec25EN

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaTransactions concluded by management

The Financial Calendar of JSC Olainfarm for 2018

on December 28, 2017

JSC Olainfarm will publish its reports on following dates in 2018:

  • unaudited financial statements for 2017 on February 28, 2018;
  • unaudited interim financial statement for 3 months of 2018 on May 31, 2018;
  • unaudited interim financial statement for 6 months of 2018 on August 31, 2018;
  • unaudited interim financial statement for 9 months of 2018 on November 30, 2018.

Audited standalone and consolidated financial statements of JSC Olainfarm for 2017 will be published on April 30, 2018.

read more
SigitaThe Financial Calendar of JSC Olainfarm for 2018

Board of Olainfarm Will be Chaired by Olegs Grigorjevs

on December 18, 2017

Council of JSC Olainfarm decided to appoint CEO and Board Member of JSC Olainfarm Mr. Olegs Grigorjevs to be the new Chairman of the Board. Mr. Raimonds Terentjevs was appointed the new Board Member of JSC Olainfarm. This decision will take effect after the Enterprise Register of Latvia registers the changes to the Board of JSC Olainfarm.

Olegs Grigorjevs is Executive Director of JSC Olainfarm and the Member of the Board with more than 20 years of experience in chemical and pharmaceutical sector. O. Grigorjevs joined Olainfarm in 2001 and for many years was the Director of Commerce. Prior to that Mr. Grigorjevs was working in companies Grif Ltd. (from 2000 through 2001) and Aroma Ltd. (from 1996 through 2000). Olegs Grigorjevs has a degree in economics from Technical University of Information and Communications in Moscow.  He owns 1000 shares of JSC Olainfarm.

Raimonds Terentjevs is a director of Department of Quality Management of JSC Olainfarm. He joined JSC Olainfarm in 2011, after he left his position of researcher in Latvian Institute of Organic Synthesis. Raimonds Terentjevs has degrees of Bachelor and Master of natural sciences and chemistry from University of Latvia. He owns no shares in JSC Olainfarm.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaBoard of Olainfarm Will be Chaired by Olegs Grigorjevs

Salvis Lapins Will Remain on Olainfarm’s Management Board

on December 11, 2017

Hereby JSC Olainfarm informs that its member of the Management Board Mr. Salvis Lapins has revoked his resignation by January 12, 2018. Company’s Supervisory Council has also approved this move, therefore Mr. Lapins will continue working on the Board of JSC Olainfarm.

“I have very strong ties with Olainfarm. They have matured during more than a decade, during which we had our reasons for celebrations and we have coped with quite a few crises.  Loss of Mr. Maligins has upset our personnel, shareholders and partners very heavily. I think that my duty now is to use my experience and wisdom learned from Valerijs to help the work of his life to overcome these uneasy times,” says Salvis Lapins, member of Management Board of JSC Olainfarm.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Further information:
Sigita Zviedre
JSC Olainfarm Head of PR
Mobile: +371 26377286
E-mail: szviedre@olainfarm.lv

read more
SigitaSalvis Lapins Will Remain on Olainfarm’s Management Board

On Cancellation of the Webinar Scheduled for December 12

on December 10, 2017

JSC Olainfarm hereby informs, that 3rd quarter webinar scheduled for 4:00 p.m. Latvian time on December 12, 2017 is cancelled.

Company will publish a separate announcement on new time and date of 3rd quarter webinar.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOn Cancellation of the Webinar Scheduled for December 12

Valerijs Maligins, Chairman of the Board of JSC Olainfarm Has Passed Away

on December 10, 2017

We are extremely saddened to inform that Mr. Valerijs Maligins, main shareholder and Chairman of the Board of JSC Olainfarm has passed away yesterday in his house in Jurmala at the age of 52.

Valerijs Maligins became Chairman of Olainfarm’s Board after the privatization of the company in 1997. Under his management, the company became one of the most valuable companies in Latvia reaching the level of 100 million in its revenues and selling its products to more than 50 countries.

Mr. Valerijs Maligins has also been a Chairman of the Board in AB Endokrininiai Preparatai, Chairman of the Council in JSC Rigas Farmaceitiska Fabrika, director of pharmaceutical company Aroma Baltfarm and Alfa Dental Ltd. as well as owner and manager of many other companies.

We hereby express our deepest condolences to family, friends and colleagues of Valerijs Maligins.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaValerijs Maligins, Chairman of the Board of JSC Olainfarm Has Passed Away

Transactions concluded by management

on December 5, 2017

JSC Olainfarm has received the notification of manager on transactions with securities issued by  JSC Olainfarm. The received notification is available here:

NotificationSLENG

 

Information prepared by:

Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaTransactions concluded by management

Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

on December 4, 2017

From December 5 through December 11 Member of the Board and Investor relations officer of JSC Olainfarm Mr. Salvis Lapins will have his fourth annual road show to update investors about Olainfarm’s performance and near future intentions. Presentations will be held in capitals of five countries.

Meetings are planned on December 5 in Warsaw, December 6 in Stockholm, December 7 in Helsinki, December 8 in Tallinn and December 11 in Vilnius. More than 20 meetings have been scheduled so far and during those meetings the enclosed presentation will be distributed:

baltnord17

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors